KOBAYASHI PHARMACEUTICAL CO.,LTD.JP:4967

Market cap

¥519,111m

P/E ratio

28.2

Summary Income statement Balance sheet Cash flow

	Mar 31, 2010	Mar 31, 2011	Mar 31, 2012	Mar 31, 2013	Mar 31, 2014	Mar 31, 2015	Mar 31, 2016	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Net sales	129,184	130,824	131,166	121,532	127,293	128,344	137,211	120,051	156,761	167,479	168,052	150,514	155,252	166,258
Ordinary profit (loss)	17,071	19,010	20,092	18,677	18,769	18,843	17,949	19,499	24,191	27,374	27,851	27,726	28,015	28,281
Profit (loss) attributable to owners of parent
Comprehensive income
Basic earnings (loss) per share
Diluted earnings per share
Net cash provided by (used in) operating activities
Net cash provided by (used in) investing activities
Net cash provided by (used in) financing activities